Acadia Pharma Q1 2024 Earnings Preview
by
Contributor since / Followers
Contributor since / Followers
4 months ago
- Acadia Pharma (NASDAQ:ACAD) is scheduled to announce Q1 earnings results on Wednesday, May 8th, after market close.
- The consensus EPS Estimate is $0.06 (+122.2% Y/Y) and the consensus Revenue Estimate is $208.58M (+76.1% Y/Y).
- Over the last 1 year, ACAD has beaten EPS estimates 50% of the time and has beaten revenue estimates 25% of the time.
- Over the last 3 months, EPS estimates have seen 0 upward revisions and 9 downward. Revenue estimates have seen 0 upward revisions and 9 downward.